FibroBiologics Balance Sheet Health
Financial Health criteria checks 3/6
FibroBiologics has a total shareholder equity of $2.7M and total debt of $115.0K, which brings its debt-to-equity ratio to 4.2%. Its total assets and total liabilities are $10.5M and $7.7M respectively.
Key information
4.2%
Debt to equity ratio
US$115.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$7.83m |
| Equity | US$2.74m |
| Total liabilities | US$7.73m |
| Total assets | US$10.47m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: FBLG's short term assets ($8.2M) exceed its short term liabilities ($6.7M).
Long Term Liabilities: FBLG's short term assets ($8.2M) exceed its long term liabilities ($1.1M).
Debt to Equity History and Analysis
Debt Level: FBLG has more cash than its total debt.
Reducing Debt: Insufficient data to determine if FBLG's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FBLG has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: FBLG has less than a year of cash runway if free cash flow continues to reduce at historical rates of 43.6% each year